Robert Holmlin

Robert Holmlin

Direktör/Styrelseledamot på
Xagenic, Inc.

Förmögenhet: 1 208 $ per 2026-08-31

58 år
Health Technology
Consumer Services
Finance

Profil

Robert Erik Holmlin was the founder of GeneOhm Sciences, Inc., founded in 2001, where the title held was Vice President-Business Development from 2001 to 2012.
Current jobs include Director at Xagenic, Inc. since 2012 and Director at Innovatus Life Sciences Acquisition Corp.
since 2021.
Former jobs include President, CEO, CFO & Director at Bionano Genomics, Inc. from 2024 to 2026; President & Chief Executive Officer at GenVault Corp.
from 2010 to 2011; Independent Director at Nanosphere, Inc.; Director at Applied Proteomics, Inc.; Entrepreneur-in-Residence at Domain Associates LLC; Vice President-Marketing & Development at Becton, Dickinson & Co. from 2006 to 2008; and Chief Commercial Officer at Exiqon A from 2008 to 2009.
Education includes an MBA from The Trustees of Columbia University in The City of New York, a doctorate from California Institute of Technology, an undergraduate degree from Occidental College, and an MBA from the University of California, Berkeley.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-03-19 990 ( 0,01 % ) 1 208 $ 2026-08-31

Aktiva positioner av Robert Holmlin

FöretagPositionStart
Direktör/Styrelseledamot 2012-09-11
Direktör/Styrelseledamot 2021-03-01

Tidigare kända positioner av Robert Holmlin

FöretagPositionSlut
BIONANO GENOMICS, INC. Verkställande Direktör 2026-05-05
Verkställande Direktör 2011-02-01
EXIQON A/S Företagsledare/Principal 2009-11-01
BECTON, DICKINSON AND COMPANY Försäljning & Marknadsföring 2008-07-01
Företagsledare/Principal -
Se detaljerna i Robert Holmlins erfarenhet

Robert Holmlins utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

  1. Börsen
  2. Insiders
  3. Robert Holmlin
-40% : Prolongation exceptionnelle ➤➤➤➤
d
:
:
TA DEL AV DET NU